Takeda investors back $59 billion Shire deal, but wary of debt load
2018-12-5 03:51 pm
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Read The Rest at
Thomas Cook shares climb 45 percent but bonds...
Thyssenkrupp's top shareholder appoints...
You May Also Like
How to get back 'Other' storage on the iPhone...
Big Tech Companies Want to Help Get You Back in...
Reel Life: As Movies Reopen, Projectionist...
Prince Harry, Meghan Markle Sign Major Netflix...
AP Explains: US debt will soon exceed size of...
Pentagon reaffirms Microsoft as winner of...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version